Topics in Breast and Gynecologic Cancers
Saturday, March 24, 2012
8:00 am – 12:30 pm
Dana-Farber Cancer Institute
Jimmy Fund Auditorium
Boston, MA
Offered by Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School Department of Continuing Education
Quicklinks
Course Overview | Agenda | Faculty
Registration Information | Credits
Course Overview & Learning Objectives
Clinicians need to stay current in their knowledge of high-risk genetic cancer syndromes and appropriate treatment options. New discoveries of genes that lead to increased cancer risk are occurring quickly, as are the therapies targeting those genes. This half-day course for medical, radiation, and gynecologic oncologists, gynecologists, OB/GYNs, primary care physicians, and other clinicians involved in women’s health, will enhance practitioners’ knowledge in this area. Through lecture, case presentations, and Q&A, attendees will learn how to assess and manage risk for breast and gynecologic cancers, as well as understand genetic and lifestyle risk factors. In addition, specialists will provide updates on treatments for breast, ovarian, and endometrial cancers.
At the conclusion of this course, attendees will be able to: identify individuals who are at high cancer risk; integrate this knowledge about high-risk familial cancer syndromes into their practice; and utilize new advances in triple negative breast cancer, HER2+ breast cancer, high-risk newly diagnosed endometrial cancer, and recurrent ovarian cancer, and apply this knowledge into direct patient care.
About the Susan F. Smith Center for Women's Cancers at Dana-Farber/Brigham and Women's Cancer Center
The Susan F. Smith Center for Women's Cancers brings together a team of renowned experts in breast and gynecologic cancers to provide women with the most promising cancer treatments available. With an equal commitment to clinical research and care, the faculty is able to facilitate the rapid conversion of scientific discoveries into lifesaving treatments.
In addition to offering the latest treatments, the Center also provides a wide range of specialized treatment programs and other services – from support groups to complementary therapies – to help meet the diverse needs of women facing cancer.
Agenda
8:00 am
Registration and Continental Breakfast
Session I: Determining Breast and Gynecologic Risk
Moderator: J. Dirk Iglehart, MD
8:30 am
Family History: Asking the Right Questions, Documenting Records
Katherine Schneider, MPH, CGC
8:50 am
Genes/Syndromes of Concern for Women's Cancers
Judy E. Garber, MD, MPH
9:10 am
Vitamins, Diet, and Risk: What We Know from Population Studies
Rulla M. Tamimi, MSc, ScD
9:30 am
Case Presentations Related to High Risk Syndromes Seen in Practices
Beth Overmoyer, MD, FACP
9:50 am
Questions
10:10 am
Break
Session II: Treatment Updates in Breast and Gynecologic Cancers
Moderator: Ursula A. Matulonis, MD
10:25 am
HER2 Positive Breast Cancer
Sara M. Tolaney, MD, MPH
10:45 am
Triple Negative Breast Cancer
Nancy U. Lin, MD
11:05 am
Questions
11:20 am
When to Use Adjuvant Chemotherapy for Endometrial Cancer
Andrea P. Myers, MD, PhD
11:40 am
Recurrent Ovarian Cancer
Ursula A. Matulonis, MD
12:00 pm
Questions
12:15 pm
Concluding Remarks
Faculty
J. Dirk Iglehart, MD, Course Co-Director
Director, Susan F. Smith Center for Women's Cancers
Dana-Farber/Brigham and Women's Cancer Center;
Anne E. Dyson Professor of Women's Cancers and Surgery
Harvard Medical School
Ursula A. Matulonis, MD, Course Co-Director
Medical Director, Gynecologic Oncology, Susan F. Smith Center for Women's Cancers
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine
Harvard Medical School
Judy E. Garber, MD, MPH
Director, Center for Cancer Genetics and Prevention
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Medicine
Harvard Medical School
Nancy U. Lin, MD
Medical Oncologist, Breast Oncology
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine
Harvard Medical School
Andrea P. Myers, MD, PhD
Medical Oncologist, Gynecologic Oncology
Dana-Farber/Brigham and Women's Cancer Center;
Instructor in Medicine
Harvard Medical School
Beth Overmoyer, MD, FACP
Medical Oncologist, Breast Oncology
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine
Harvard Medical School
Katherine Schneider, MPH, CGC
Senior Genetic Counselor
Center for Cancer Genetics and Prevention
Dana-Farber/Brigham and Women's Cancer Center
Rulla M. Tamimi, MSc, ScD
Epidemiologist
Brigham and Women's Hospital;
Associate Professor of Medicine
Harvard Medical School
Sara M. Tolaney, MD, MPH
Medical Oncologist, Breast Oncology
Dana-Farber/Brigham and Women's Cancer Center;
Instructor in Medicine
Harvard Medical School
Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.
CME Credits
The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.
The Harvard Medical School designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Registration Information
Registration Fee: $50.00 (non-refundable).
Registration fee includes: continental breakfast, course materials, and complimentary parking
To register by mail
Send completed registration form and check made payable to DF/BWCC to the address below:
Women’s Cancers CME
Attn: Kamira Wooten
450 Brookline Avenue, OS 381
Boston, MA 02215
The registration form must be postmarked no later than March 9, 2012.
If you have food allergies, or if you require accommodations such as an ASL interpreter, materials in alternative format or wheelchair access, please email kwooten@partners.org or call 800-553-3787.
For directions to Dana-Farber, please visit: www.dana-farber.org/directions.
